Christopher J. Cheng

4.6k total citations · 1 hit paper
26 papers, 3.0k citations indexed

About

Christopher J. Cheng is a scholar working on Molecular Biology, Cancer Research and Biomaterials. According to data from OpenAlex, Christopher J. Cheng has authored 26 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Biomaterials. Recurrent topics in Christopher J. Cheng's work include RNA Interference and Gene Delivery (13 papers), MicroRNA in disease regulation (8 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Christopher J. Cheng is often cited by papers focused on RNA Interference and Gene Delivery (13 papers), MicroRNA in disease regulation (8 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Christopher J. Cheng collaborates with scholars based in United States, Australia and Singapore. Christopher J. Cheng's co-authors include W. Mark Saltzman, Frank J. Slack, Imran Babar, Owen G. Jones, Jennifer K. Saucier-Sawyer, Gregory T. Tietjen, Carmen J. Booth, Demetrios T. Braddock, Joanne B. Weidhaas and Xianping Liang and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Christopher J. Cheng

25 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA silencing for cancer therapy targeted to the tumour microenvironment

2014 683 citations Christopher J. Cheng, Raman Bahal et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher J. Cheng United States	21	2.1k	982	573	431	221	26	3.0k
Weimin Fan China	34	1.9k 0.9×	767 0.8×	549 1.0×	376 0.9×	113 0.5×	63	3.5k
Hui Xue China	27	1.6k 0.8×	434 0.4×	726 1.3×	570 1.3×	113 0.5×	101	2.9k
Kai‐Tai Yao China	35	2.0k 0.9×	1.0k 1.0×	473 0.8×	518 1.2×	158 0.7×	121	3.9k
Xia Zhao China	36	1.8k 0.9×	819 0.8×	701 1.2×	318 0.7×	339 1.5×	118	4.1k
Wenquan Liang China	31	1.4k 0.7×	365 0.4×	635 1.1×	346 0.8×	175 0.8×	124	2.9k
Deepak Chitkara India	29	1.4k 0.7×	519 0.5×	755 1.3×	510 1.2×	72 0.3×	87	2.7k
Hyejung Mok South Korea	39	3.0k 1.4×	496 0.5×	1.4k 2.4×	1.1k 2.6×	371 1.7×	113	4.5k
Marcel H.A.M. Fens Netherlands	28	1.7k 0.8×	583 0.6×	1.0k 1.8×	720 1.7×	112 0.5×	69	3.3k
Huiyuan Wang China	31	1.5k 0.7×	253 0.3×	903 1.6×	820 1.9×	238 1.1×	70	2.9k
Ling Ding China	36	2.2k 1.0×	800 0.8×	507 0.9×	589 1.4×	116 0.5×	135	4.2k

Countries citing papers authored by Christopher J. Cheng

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Cheng more than expected).

Fields of papers citing papers by Christopher J. Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Cheng. The network helps show where Christopher J. Cheng may publish in the future.

Co-authorship network of co-authors of Christopher J. Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Cheng. A scholar is included among the top collaborators of Christopher J. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Cheng. Christopher J. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reiss, C.W., et al.. (2025). Engineered chimeric T7 RNA polymerase improves salt tolerance and reduces dsRNA impurity generation during in vitro transcription of mRNA. Nucleic Acids Research. 53(21).

Cheng, Christopher J. & Owen G. Jones. (2019). Effect of drying temperature and extent of particle dispersion on composite films of methylcellulose and zein nanoparticles. Journal of Food Engineering. 250. 26–32. 12 indexed citations

Adams, Brian D., Hannah Arem, Monica J. Hubal, et al.. (2018). Exercise and weight loss interventions and miRNA expression in women with breast cancer. Breast Cancer Research and Treatment. 170(1). 55–67. 33 indexed citations

Cheng, Christopher J., et al.. (2018). miR-155 drives oncogenesis by promoting and cooperating with mutations in the c-Kit oncogene. Oncogene. 38(12). 2151–2161. 22 indexed citations

Cheng, Lei, et al.. (2018). Arginase I mRNA therapy – a novel approach to rescue arginase 1 enzyme deficiency. RNA Biology. 15(7). 914–922. 42 indexed citations

Farelli, Jeremiah D., et al.. (2018). Leveraging Rational Protein Engineering to Improve mRNA Therapeutics. Nucleic Acid Therapeutics. 28(2). 74–85. 7 indexed citations

Jiang, Yuhang, Alice Gaudin, Junwei Zhang, et al.. (2018). A “top-down” approach to actuate poly(amine-co-ester) terpolymers for potent and safe mRNA delivery. Biomaterials. 176. 122–130. 62 indexed citations

Farelli, Jeremiah D., Mary R. Stahley, Rebecca L. Miller, et al.. (2018). Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA. RNA Biology. 15(6). 1–7. 91 indexed citations

Cheng, Christopher J. & Owen G. Jones. (2017). Stabilizing zein nanoparticle dispersions with ι-carrageenan. Food Hydrocolloids. 69. 28–35. 124 indexed citations

10.

Adams, Brian D., Vikram B. Wali, Christopher J. Cheng, et al.. (2015). miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer. Cancer Research. 76(4). 927–939. 128 indexed citations

11.

Saucier-Sawyer, Jennifer K., Yang Deng, Young-Eun Seo, et al.. (2015). Systemic delivery of blood–brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue. Journal of drug targeting. 23(7-8). 736–749. 77 indexed citations

12.

Cheng, Christopher J., Gregory T. Tietjen, Jennifer K. Saucier-Sawyer, & W. Mark Saltzman. (2015). A holistic approach to targeting disease with polymeric nanoparticles. Nature Reviews Drug Discovery. 14(4). 239–247. 381 indexed citations

13.

Seo, Young-Eun, et al.. (2015). Enhancing potency of siRNA targeting fusion genes by optimization outside of target sequence. Proceedings of the National Academy of Sciences. 112(48). E6597–605. 12 indexed citations

14.

Cheng, Christopher J., Raman Bahal, Imran Babar, et al.. (2014). MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature. 518(7537). 107–110. 683 indexed citations breakdown →

15.

Martin, Darryl T., Christopher Hoimes, Hristos Z. Kaimakliotis, et al.. (2013). Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer. Nanomedicine Nanotechnology Biology and Medicine. 9(8). 1124–1134. 51 indexed citations

16.

Babar, Imran, Christopher J. Cheng, Carmen J. Booth, et al.. (2012). Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proceedings of the National Academy of Sciences. 109(26). E1695–704. 399 indexed citations

17.

Fields, Rachel J., Christopher J. Cheng, Elias Quijano, et al.. (2012). Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery. Journal of Controlled Release. 164(1). 41–48. 72 indexed citations

18.

Cheng, Christopher J. & Frank J. Slack. (2012). The Duality of OncomiR Addiction in the Maintenance and Treatment of Cancer. The Cancer Journal. 18(3). 232–237. 45 indexed citations

19.

Cheng, Christopher J. & W. Mark Saltzman. (2011). Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides. Biomaterials. 32(26). 6194–6203. 101 indexed citations

20.

Zhou, Jiangbing, Jie Liu, Christopher J. Cheng, et al.. (2011). Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery. Nature Materials. 11(1). 82–90. 338 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact